BrightIntel
Latest round
- Series A
Last raised
- Oct 2025
Total raised
- Undisclosed
Investors
- 2
About BrightIntel
, trading as BrightIntel specializes in AI-driven drug development. BrightIntel focuses on the development of innovative drug therapies using AI-driven platforms. Their primary offerings include an AI drug discovery platform that employs deep learning and big data analytics to improve molecular activity predictions, and a proprietary drug delivery technology that enhances therapeutic effectiveness while minimizing side effects. Through these offerings, the company aims to serve pharmaceutical companies and healthcare providers globally, particularly in North America and Europe, with an emphasis on providing safer alternatives to traditional opioid therapies. BrightIntel generates revenue through strategic collaborations with pharmaceutical companies and healthcare organizations that implement its AI-driven drug discovery and delivery solutions. Its revenue model includes milestone payments based on the developmental phases of drug candidates, alongside potential B2B licensing agreements for its advanced drug delivery systems and AI platforms, particularly focused on pain management therapeutic applications.
Who invested in BrightIntel
2 investors across 1 round
See all investors in BrightIntel
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Oct 31, 2025
Amount
Undisclosed
Investors
Questions about BrightIntel
Who invested in BrightIntel?
BrightIntel has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has BrightIntel raised?
BrightIntel has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did BrightIntel last raise money?
BrightIntel's most recent round on record is a Series A, in Oct 2025.
What does BrightIntel do?
, trading as BrightIntel specializes in AI-driven drug development.
Where is BrightIntel headquartered?
BrightIntel is headquartered in Suzhou, China.
Which VCs invest in companies like BrightIntel?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at BrightIntel's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like BrightIntel? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.